• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Progress with new malaria vaccines.新型疟疾疫苗的进展。
Bull World Health Organ. 2003;81(12):902-9. Epub 2004 Mar 1.
2
Plasmodium falciparum malaria vaccines in development.正在研发的恶性疟原虫疟疾疫苗。
Expert Rev Vaccines. 2008 Mar;7(2):223-40. doi: 10.1586/14760584.7.2.223.
3
Progress towards the development of malaria vaccines.疟疾疫苗研发进展
Trends Parasitol. 2006 Jul;22(7):292-5. doi: 10.1016/j.pt.2006.05.002. Epub 2006 May 16.
4
[Immunology in medical practice. XXVII. Vaccines against malaria: new perspectives].[医学实践中的免疫学。第二十七篇。抗疟疾疫苗:新视角]
Ned Tijdschr Geneeskd. 2000 Jan 8;144(2):64-9.
5
Randomised trial of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.在坦桑尼亚南部儿童中开展的针对恶性疟原虫疟疾的SPf66疫苗随机试验。
Med Trop (Mars). 1995;55(4 Suppl):41-6.
6
New malaria vaccine shows promise.
West J Med. 1999 May;170(5):304.
7
Advances in vaccine development against the pre-erythrocytic stage of Plasmodium falciparum malaria.针对恶性疟原虫疟疾红细胞前期阶段疫苗研发的进展
Expert Rev Vaccines. 2006 Feb;5(1):81-93. doi: 10.1586/14760584.5.1.81.
8
[Achievements and perspectives of research into development of a vaccine against malaria].[疟疾疫苗研发的研究成果与展望]
Wiad Parazytol. 2010;56(2):133-40.
9
A review of human vaccine research and development: malaria.人类疫苗研发综述:疟疾
Vaccine. 2007 Feb 19;25(9):1567-80. doi: 10.1016/j.vaccine.2006.09.074. Epub 2006 Oct 5.
10
[Malaria vaccines: why, who and how?].[疟疾疫苗:为何、针对何人以及如何研发?]
Med Trop (Mars). 1995;55(4 Suppl):47-51.

引用本文的文献

1
[Not Available].[无可用内容]
Antibiotiques (Paris). 2004 Dec;6(4):219-221. doi: 10.1016/S1294-5501(04)94267-7. Epub 2008 Jan 3.
2
Immunogenic Evaluation of Ribosomal P-Protein Antigen P0, P1, and P2 and Pentameric Protein Complex P0-(P1-P2) of in a Mouse Model.核糖体 P 蛋白抗原 P0、P1 和 P2 以及五聚体蛋白复合物 P0-(P1-P2)在小鼠模型中的免疫原性评价。
J Immunol Res. 2019 Sep 12;2019:9264217. doi: 10.1155/2019/9264217. eCollection 2019.
3
Immune Responses to the Sexual Stages of Parasites.寄生虫有性阶段的免疫反应。
Front Immunol. 2019 Feb 11;10:136. doi: 10.3389/fimmu.2019.00136. eCollection 2019.
4
Genetic approach towards a vaccine against malaria.针对疟疾的疫苗的遗传方法。
Eur J Clin Microbiol Infect Dis. 2018 Oct;37(10):1829-1839. doi: 10.1007/s10096-018-3313-8. Epub 2018 Jun 28.
5
Dendritic Cells and Their Multiple Roles during Malaria Infection.树突状细胞及其在疟疾感染过程中的多种作用。
J Immunol Res. 2016;2016:2926436. doi: 10.1155/2016/2926436. Epub 2016 Mar 24.
6
High-Level Expression, Purification and Characterization of A Recombinant Plasmodium vivax Apical Membrane Antigen 1: Implication for vivax Malaria Vaccine Development.间日疟原虫顶端膜抗原1的重组表达、纯化及特性分析:对间日疟疫苗开发的意义
Cell J. 2015 Fall;17(3):520-31. doi: 10.22074/cellj.2015.12. Epub 2015 Oct 7.
7
Identification of a highly antigenic linear B cell epitope within Plasmodium vivax apical membrane antigen 1 (AMA-1).鉴定间日疟原虫顶膜蛋白 1(AMA-1)中的一个高抗原线性 B 细胞表位。
PLoS One. 2011;6(6):e21289. doi: 10.1371/journal.pone.0021289. Epub 2011 Jun 21.
8
Nucleotide sequence polymorphism at the apical membrane antigen-1 locus reveals population history of Plasmodium vivax in Thailand.顶端膜抗原-1 基因座的核苷酸序列多态性揭示了泰国间日疟原虫的种群历史。
Infect Genet Evol. 2009 Dec;9(6):1295-300. doi: 10.1016/j.meegid.2009.07.005. Epub 2009 Jul 28.
9
Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3.针对恶性疟原虫疟疾的长期临床保护作用与针对裂殖子表面蛋白3的IgG3抗体密切相关。
PLoS Med. 2007 Nov 13;4(11):e320. doi: 10.1371/journal.pmed.0040320.
10
Towards an effective malaria vaccine.迈向有效的疟疾疫苗。
Arch Dis Child. 2007 Jun;92(6):476-9. doi: 10.1136/adc.2005.092551.

新型疟疾疫苗的进展。

Progress with new malaria vaccines.

作者信息

Webster Daniel, Hill Adrian V S

机构信息

Nuffield Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, England.

出版信息

Bull World Health Organ. 2003;81(12):902-9. Epub 2004 Mar 1.

PMID:14997243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2572374/
Abstract

Malaria is a parasitic disease of major global health significance that causes an estimated 2.7 million deaths each year. In this review we describe the burden of malaria and discuss the complicated life cycle of Plasmodium falciparum, the parasite responsible for most of the deaths from the disease, before reviewing the evidence that suggests that a malaria vaccine is an attainable goal. Significant advances have recently been made in vaccine science, and we review new vaccine technologies and the evaluation of candidate malaria vaccines in human and animal studies worldwide. Finally, we discuss the prospects for a malaria vaccine and the need for iterative vaccine development as well as potential hurdles to be overcome.

摘要

疟疾是一种具有重大全球健康意义的寄生虫病,每年估计导致270万人死亡。在本综述中,我们描述了疟疾的负担,并讨论了恶性疟原虫复杂的生命周期,该寄生虫导致了该疾病的大部分死亡,然后回顾了表明疟疾疫苗是一个可实现目标的证据。疫苗科学最近取得了重大进展,我们综述了新的疫苗技术以及全球范围内在人体和动物研究中对候选疟疾疫苗的评估。最后,我们讨论了疟疾疫苗的前景、迭代疫苗开发的必要性以及需要克服的潜在障碍。